Trial Profile
Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2017
Price :
$35
*
At a glance
- Drugs Cilnidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms ACHIEVE ONE
- Sponsors Ajinomoto
- 20 Aug 2017 Results published in the Journal of Clinical Hypertension (Greenwich)
- 10 May 2011 New trial record